Circulating endothelial progenitor cells during normal pregnancy and pre-eclampsia

Keiichi Matsubara1, Emiko Abe, Yuko Matsubara

  • 1Department of Obstetrics and Gynecology, Ehime University School of Medicine, Japan. keiichi@m.ehime-u.ac.jp

Insights

Endothelial progenitor cell (EPC) proliferation is increased in pre-eclampsia (PE), despite similar cell numbers. Angiotensin II and TNF-alpha stimulate EPC proliferation in PE, suggesting a role in utero-placental circulation disturbances.

Area of Science:

  • Reproductive biology
  • Vascular biology
  • Cellular biology

Background:

  • Endothelial progenitor cells (EPCs) are crucial for neovascularization in the uterine endometrium and utero-placental circulation.
  • Pre-eclampsia (PE) is a pregnancy complication characterized by impaired utero-placental circulation.

Purpose of the Study:

  • To investigate differences in EPC proliferation between normal pregnancy and pre-eclampsia.
  • To determine the role of Angiotensin II (Ang II) and Tumor Necrosis Factor-alpha (TNF-alpha) in EPC proliferation in PE.

Main Methods:

  • Quantified peripheral blood EPC numbers using flow cytometry in non-pregnant, normal pregnant, and PE groups.
  • Assessed EPC proliferation via acetylated LDL uptake and lectin binding after 7-day culture.
  • Measured EPC proliferative activity induced by Ang II and TNF-alpha using BrdU assay.

Main Results:

  • No significant difference in peripheral blood EPC numbers between PE and normal pregnancy groups.
  • Significantly increased EPC proliferation observed in patients with PE compared to normal pregnancy.
  • Ang II and TNF-alpha demonstrably induced proliferation of EPCs from PE patients.

Conclusions:

  • While EPC proliferation is enhanced in PE, potentially stimulated by factors like Ang II and TNF-alpha, impaired EPC mobilization may hinder EC regeneration.
  • Serum factors might impair EPC mobilization, contributing to insufficient EC regeneration in the disturbed utero-placental circulation of PE.
Abstract